Dr Tianqing (Michelle) Liu joined NICM Health Research Institute in 2020 as a Western Sydney University Vice-Chancellor’s Senior Research Fellow working in the area of pharmacology and natural product chemistry. She has a long-standing interest in human cancers and neurological disorders, with her current research focusing on the use of nanotechnology to overcome medical barriers in disease diagnosis and therapy. Dr Liu has been recognised for scientific excellence with several grants, fellowships and awards, including the 2015 Women in Technology Rising Star Award, and in 2019, she was a finalist for L'Oréal-UNESCO For Women in Science Australian & New Zealand Fellowship for her work in developing nanomedicines for disease diagnosis and treatment. She is highly productive in her research, and this has led to her work being featured in >90 original research publications in leading journals such as ACS NANO (IF 15.9), Nano Letters (IF 11.2), Biomaterials (IF 12.5), and ACS Applied Materials & Interfaces (IF 9.2). She has given >30 presentations at national/international conferences, and for 15 of these presentations, she was an invited speaker. Dr Liu has received significant research funding from various competitive funding agencies, with the total amount of funds she has received being over USD 2 million.